|
WO2019018306A1
|
|
Scalable microparticulate formulations containing micronized polymorphic nimodipine form 2
|
|
WO2018039039A1
|
|
Scalable microparticulate formulations containing polymorphic nimodipine form 2 prepared by a solvent evaporation process
|
|
US2018055813A1
|
|
Compositions and methods for treating atrial fibrillation
|
|
US2019054022A1
|
|
Formulations of site-specific, microparticulate compositions and their use to improve outcome after aneursymal subarachnoid hemorrhage
|
|
US2016346224A1
|
|
Compositions and methods for reducing visual loss
|
|
AU2016201681A1
|
|
A drug delivery system for the prevention of cerebral vasospasm
|
|
AU2013203192A1
|
|
A drug delivery system for the prevention of cerebral vasospasm
|
|
US2013302431A1
|
|
Polymorph compositions, methods of making, and uses thereof
|
|
US2013243864A1
|
|
Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
|
|
AU2011217777A1
|
|
Methods and compositions to treat hemorrhagic conditions of the brain
|
